NovaBay Pharmaceuticals, Inc.
(NYSE Amex Equities : NBY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.81%204.541.3%$443.31m
BIIBBiogen Inc.
0.35%226.551.3%$383.62m
GILDGilead Sciences, Inc.
1.36%65.390.9%$367.20m
CELGCelgene Corporation
0.59%100.981.3%$354.45m
ILMNIllumina, Inc.
0.51%311.903.5%$268.06m
REGNRegeneron Pharmaceuticals, Inc.
-0.37%304.302.6%$218.92m
EXASExact Sciences Corporation
4.92%99.5224.1%$209.20m
ALXNAlexion Pharmaceuticals, Inc.
3.23%104.612.0%$186.90m
VRTXVertex Pharmaceuticals Incorporated
1.53%176.251.9%$181.57m
AAgilent Technologies, Inc.
0.89%75.851.6%$155.14m
SRPTSarepta Therapeutics, Inc.
2.96%88.2414.6%$145.92m
ALDRAlder Biopharmaceuticals, Inc.
-0.19%18.8910.2%$132.12m
BMRNBioMarin Pharmaceutical Inc.
1.99%68.584.3%$97.86m
ACADACADIA Pharmaceuticals Inc.
1.47%40.0613.4%$90.89m
NKTRNektar Therapeutics
9.42%17.375.5%$86.15m

Company Profile

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.